• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

首例吡咯里西啶生物碱 N-氧化物诱导的肝窦阻塞综合征的人类证据。

First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.

机构信息

School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, SAR, Hong Kong.

Joint Research Laboratory for Promoting Globalization of Traditional Chinese Medicines Between Shanghai Institute of Materia Medica, Chinese Academy of Sciences and The Chinese University of Hong Kong, Hong Kong, People's Republic of China.

出版信息

Arch Toxicol. 2017 Dec;91(12):3913-3925. doi: 10.1007/s00204-017-2013-y. Epub 2017 Jun 15.

DOI:10.1007/s00204-017-2013-y
PMID:28620673
Abstract

Pyrrolizidine alkaloids (PAs) are among the most potent phytotoxins widely distributed in plant species around the world. PA is one of the major causes responsible for the development of hepatic sinusoidal obstruction syndrome (HSOS) and exerts hepatotoxicity via metabolic activation to form the reactive metabolites, which bind with cellular proteins to generate pyrrole-protein adducts, leading to hepatotoxicity. PA N-oxides coexist with their corresponding PAs in plants with varied quantities, sometimes even higher than that of PAs, but the toxicity of PA N-oxides remains unclear. The current study unequivocally identified PA N-oxides as the sole or predominant form of PAs in 18 Gynura segetum herbal samples ingested by patients with liver damage. For the first time, PA N-oxides were recorded to induce HSOS in human. PA N-oxide-induced hepatotoxicity was further confirmed on mice orally dosed of herbal extract containing 170 μmol PA N-oxides/kg/day, with its hepatotoxicity similar to but potency much lower than the corresponding PAs. Furthermore, toxicokinetic study after a single oral dose of senecionine N-oxide (55 μmol/kg) on rats revealed the toxic mechanism that PA N-oxides induced hepatotoxicity via their biotransformation to the corresponding PAs followed by the metabolic activation to form pyrrole-protein adducts. The remarkable differences in toxicokinetic profiles of PAs and PA N-oxides were found and attributed to their significantly different hepatotoxic potency. The findings of PA N-oxide-induced hepatotoxicity in humans and rodents suggested that the contents of both PAs and PA N-oxides present in herbs and foods should be regulated and controlled in use.

摘要

吡咯里西啶生物碱(PA)是世界范围内广泛分布于植物物种中的最有效植物毒素之一。PA 是导致肝窦阻塞综合征(HSOS)发展的主要原因之一,通过代谢激活形成反应性代谢物发挥其肝毒性,这些代谢物与细胞蛋白结合生成吡咯蛋白加合物,导致肝毒性。PA N-氧化物与植物中的相应 PA 共存,其含量变化较大,有时甚至高于 PA,但 PA N-氧化物的毒性仍不清楚。本研究明确鉴定出 18 种 Gynura segetum 草药样本中的 PA N-氧化物是患者肝损伤中唯一或主要形式的 PA。首次记录到 PA N-氧化物在人体内诱导 HSOS。通过口服给予含有 170 μmol PA N-氧化物/公斤/天的草药提取物的小鼠,进一步证实了 PA N-氧化物引起的肝毒性,其肝毒性与相应的 PA 相似,但效力远低于相应的 PA。此外,大鼠单次口服氧化苦参碱(55 μmol/kg)后的毒代动力学研究揭示了 PA N-氧化物通过其生物转化为相应的 PA 诱导肝毒性,然后通过代谢激活形成吡咯蛋白加合物的毒性机制。发现 PA 和 PA N-氧化物的毒代动力学特征存在显著差异,这归因于它们明显不同的肝毒性效力。在人类和啮齿动物中发现 PA N-氧化物诱导的肝毒性表明,草药和食物中存在的 PA 和 PA N-氧化物的含量应在使用中受到监管和控制。

相似文献

1
First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.首例吡咯里西啶生物碱 N-氧化物诱导的肝窦阻塞综合征的人类证据。
Arch Toxicol. 2017 Dec;91(12):3913-3925. doi: 10.1007/s00204-017-2013-y. Epub 2017 Jun 15.
2
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.与食用菊三七相关的肝窦阻塞综合征。
J Hepatol. 2011 Apr;54(4):666-73. doi: 10.1016/j.jhep.2010.07.031. Epub 2010 Sep 22.
3
Intestinal and hepatic biotransformation of pyrrolizidine alkaloid N-oxides to toxic pyrrolizidine alkaloids.吡咯里西啶生物碱 N-氧化物在肠道和肝脏中的生物转化为有毒的吡咯里西啶生物碱。
Arch Toxicol. 2019 Aug;93(8):2197-2209. doi: 10.1007/s00204-019-02499-2. Epub 2019 Jun 20.
4
Absorption difference between hepatotoxic pyrrolizidine alkaloids and their N-oxides - Mechanism and its potential toxic impact.肝毒性吡咯里西啶生物碱及其 N-氧化物的吸收差异-机制及其潜在的毒性影响。
J Ethnopharmacol. 2020 Mar 1;249:112421. doi: 10.1016/j.jep.2019.112421. Epub 2019 Nov 20.
5
Pyrrolizidine Alkaloid-Induced Hepatotoxicity Associated with the Formation of Reactive Metabolite-Derived Pyrrole-Protein Adducts.吡咯里西啶生物碱诱导的肝毒性与活性代谢物衍生的吡咯蛋白加合物的形成有关。
Toxins (Basel). 2021 Oct 13;13(10):723. doi: 10.3390/toxins13100723.
6
The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica.体内吡咯里西啶生物碱衍生的吡咯蛋白加合物的长期持久性:含有菊三七提取物的吡咯里西啶生物碱多次暴露后的动力学研究。
Toxicol Lett. 2020 May 1;323:41-47. doi: 10.1016/j.toxlet.2020.01.021. Epub 2020 Jan 23.
7
Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.吡咯里西啶生物碱对人肝实质细胞和肝窦内皮细胞的细胞毒性:活性代谢产物介导吡咯里西啶生物碱诱导肝毒性的确凿证据。
Chem Biol Interact. 2016 Jan 5;243:119-26. doi: 10.1016/j.cbi.2015.09.011. Epub 2015 Sep 10.
8
The toxicokinetic and metabolism of structurally diverse pyrrolizidine alkaloids in rats.结构多样的吡咯里西啶生物碱在大鼠体内的毒代动力学和代谢。
J Ethnopharmacol. 2024 Mar 1;321:117390. doi: 10.1016/j.jep.2023.117390. Epub 2023 Nov 11.
9
Gynura Rhizoma containing pyrrolizidine alkaloids induces the hepatic sinusoidal obstruction syndrome in mice via upregulating fibrosis-related factors.莪术根茎含吡咯里西啶生物碱,通过上调纤维化相关因子诱导小鼠肝窦阻塞综合征。
Acta Pharmacol Sin. 2019 Jun;40(6):781-789. doi: 10.1038/s41401-018-0155-y. Epub 2018 Oct 26.
10
Tusanqi and hepatic sinusoidal obstruction syndrome.土三七和肝窦阻塞综合征。
J Dig Dis. 2014 Mar;15(3):105-7. doi: 10.1111/1751-2980.12112.

引用本文的文献

1
Medicinal Chemistry of Drugs with -Oxide Functionalities.含 -氧化物官能团药物的药物化学
J Med Chem. 2024 Apr 11;67(7):5168-5184. doi: 10.1021/acs.jmedchem.4c00254. Epub 2024 Mar 29.
2
In vitro-in silico study on the influence of dose, fraction bioactivated and endpoint used on the relative potency value of pyrrolizidine alkaloid N-oxides compared to parent pyrrolizidine alkaloids.关于剂量、生物活化分数和所使用的终点对吡咯里西啶生物碱氮氧化物相对于母体吡咯里西啶生物碱的相对效价的影响的体外-计算机模拟研究。
Curr Res Toxicol. 2024 Mar 1;6:100160. doi: 10.1016/j.crtox.2024.100160. eCollection 2024.
3
Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis.
经颈静脉肝内门体分流术治疗菊三七相关性肝窦阻塞综合征的获益:倾向评分匹配分析。
Cardiovasc Intervent Radiol. 2023 Jul;46(7):931-942. doi: 10.1007/s00270-023-03451-9. Epub 2023 May 24.
4
Physiologically based kinetic modeling of senecionine N-oxide in rats as a new approach methodology to define the effects of dose and endpoint used on relative potency values of pyrrolizidine alkaloid N-oxides.基于生理学的千里光碱 N-氧化物在大鼠体内的动力学建模:一种用于确定剂量和终点对吡咯里西啶生物碱 N-氧化物相对效价影响的新方法学。
Front Pharmacol. 2023 Mar 2;14:1125146. doi: 10.3389/fphar.2023.1125146. eCollection 2023.
5
Targeting erythrocyte-mediated hypoxia to alleviate lung injury induced by pyrrolizidine alkaloids.靶向红细胞介导的缺氧以减轻吡咯里西啶生物碱诱导的肺损伤。
Arch Toxicol. 2023 Mar;97(3):819-829. doi: 10.1007/s00204-023-03443-1. Epub 2023 Jan 13.
6
Genotoxicity of pyrrolizidine alkaloids in metabolically inactive human cervical cancer HeLa cells co-cultured with human hepatoma HepG2 cells.吡咯里西啶生物碱在与人肝癌 HepG2 细胞共培养的代谢不活跃人宫颈癌 HeLa 细胞中的遗传毒性。
Arch Toxicol. 2023 Jan;97(1):295-306. doi: 10.1007/s00204-022-03394-z. Epub 2022 Oct 23.
7
Risk Assessment of (Herbal) Teas Containing Pyrrolizidine Alkaloids (PAs) Based on Margin of Exposure Approach and Relative Potency (REP) Factors.基于暴露边际法和相对效力(REP)因子对含吡咯里西啶生物碱(PAs)的(草本)茶进行风险评估。
Foods. 2022 Sep 21;11(19):2946. doi: 10.3390/foods11192946.
8
Correlation Investigation between Pyrrole-DNA and Pyrrole-Protein Adducts in Male ICR Mice Exposed to Retrorsine, a Hepatotoxic Pyrrolizidine Alkaloid.反式-9,10-二羟-9,10-二氢吖啶(Retrorsine)致雄性 ICR 小鼠吡咯-DNA 和吡咯-蛋白加合物的相关性研究。
Toxins (Basel). 2022 May 28;14(6):377. doi: 10.3390/toxins14060377.
9
Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation.甘草提取物和18β-甘草次酸通过抑制细胞色素P450介导的代谢活化来预防实验性吡咯里西啶生物碱诱导的大鼠肝毒性。
Front Pharmacol. 2022 Mar 16;13:850859. doi: 10.3389/fphar.2022.850859. eCollection 2022.
10
Hepatotoxicity of Pyrrolizidine Alkaloid Compound Intermedine: Comparison with Other Pyrrolizidine Alkaloids and Its Toxicological Mechanism.吡咯里西啶生物碱化合物中间体的肝毒性:与其他吡咯里西啶生物碱的比较及其毒理学机制。
Toxins (Basel). 2021 Nov 28;13(12):849. doi: 10.3390/toxins13120849.